← All companies ← HMN Manual HNI → ← GRVY IT Services & Consulting IBEX →
HNGE, Hinge Health Inc.
We are a research-led organization and routinely expand our platform with new programs, capabilities, and features.
Hinge Health leverages software, including AI, to automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients and members.
We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- Situation
- Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand.
- What moves the needle
- Operating margin has run around −45% through the cycle on a 77% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. The cash cycle has run negative through the cycle (a median of −86 days): the operation is paid before it pays, so working capital releases cash as the business grows rather than tying it up. Read this kind of business on retention and the cost of growth. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2023–2025
realized figures from each filing · older years to the left| 2023’23 | 2024’24 | 2025’25 | TTMTTMMar 2026 | |
|---|---|---|---|---|
| Income statement | ||||
| $293M | $390M | $588M | $646M | RevenueRevenue |
| 66% | 77% | 80% | 81% | Gross marginGross mgn |
| 23% | 16% | 56% | 52% | SG&A / revenueSG&A/rev |
| 38% | 26% | 63% | 58% | R&D / revenueR&D/rev |
| ($131M) | ($32M) | ($546M) | ($527M) | Operating incomeOp. inc. |
| −44.6% | −8.2% | −92.9% | −81.6% | Operating marginOp. mgn |
| ($108M) | ($12M) | ($528M) | ($510M) | Net incomeNet inc. |
| Cash flow & returns | ||||
| ($64M) | $49M | $171M | $210M | Operating cash flowOp. cash |
| $6M | $6M | $5M | $5M | DepreciationDeprec. |
| $37M | $54M | $52M | $60M | Working capital & otherWC & other |
| $2M | $1M | $708K | $740K | CapexCapex |
| 0.7% | 0.3% | 0.1% | 0.1% | Capex / revenueCapex/rev |
| ($66M) | $48M | $171M | $209M | Owner earningsOwner earn. |
| −22.5% | 12.3% | 29.0% | 32.3% | Owner earnings marginOE mgn |
| ($66M) | $48M | $171M | $209M | Free cash flowFCF |
| −22.5% | 12.3% | 29.0% | 32.3% | Free cash flow marginFCF mgn |
| $0 | $0 | $4M | $0 | AcquisitionsAcquis. |
| $0 | $0 | $65M | — | BuybacksBuybacks |
| — | — | -296% | -457% | Return on equityROE |
| — | — | −296% | −457% | Retained to equityRetained/eq |
| Balance sheet | ||||
| $235M | $301M | $208M | $405M | Cash & investmentsCash+inv |
| — | $42M | $66M | $115M | ReceivablesReceiv. |
| — | $11M | $16M | $14M | InventoryInvent. |
| — | $28M | $57M | $69M | Accounts payablePayables |
| — | $26M | $24M | $60M | Operating working capitalOper. WC |
| — | $583M | $534M | $540M | Current assetsCur. assets |
| — | $249M | $362M | $414M | Current liabilitiesCur. liab. |
| — | 2.3× | 1.5× | 1.3× | Current ratioCurr. ratio |
| — | $62M | $64M | $64M | GoodwillGoodwill |
| — | $673M | $745M | $729M | Total assetsAssets |
| ($235M) | ($301M) | ($208M) | ($405M) | Net debt / (cash)Net debt |
| ($424M) | ($435M) | $179M | $112M | Shareholders’ equityEquity |
| 0.6% | 0.2% | 109.4% | 101.3% | Stock comp / revenueSBC/rev |
| Per share | ||||
| 52.1M | 54.2M | 54.6M | 82.4M | Shares out (diluted)Shares |
| $5.62 | $7.20 | $10.77 | $7.84 | Revenue / shareRev/sh |
| $-2.08 | $-0.22 | $-9.68 | $-6.19 | EPS (diluted)EPS |
| $-1.27 | $0.88 | $3.13 | $2.53 | Owner earnings / shareOE/sh |
| $-1.27 | $0.88 | $3.13 | $2.53 | Free cash flow / shareFCF/sh |
| $0.04 | $0.02 | $0.01 | $0.01 | Cap. spending / shareCapex/sh |
| $-8.14 | $-8.01 | $3.27 | $1.36 | Book value / shareBVPS |
Share counts before 2025 are restated ×4 for a stock split, so per-share figures sit on one basis.
The diluted share count moved ×1.51 into TTM — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.
The record, charted
FY2023–2025Each measure over its full record; the current point and the worst year marked. Share counts on the current split basis.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business turned a $528M loss into $171M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Reported net income | ($528M) | ($12M) | ($108M) |
| Depreciation & amortizationnon-cash charge added back | +$5M | +$6M | +$6M |
| Stock-based compensationreal costnon-cash, but a real cost | +$643M | +$739K | +$2M |
| Working capital & othertiming of cash in and out, other non-cash items | +$52M | +$54M | +$37M |
| Cash from operations | $171M | $49M | ($64M) |
| Capital expenditurecash put back in to keep running and to grow | −$708K | −$1M | −$2M |
| Owner earnings | $171M | $48M | ($66M) |
| Owner-earnings marginowner earnings ÷ revenue | 29% | 12% | -23% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $643M), owner earnings is nearer ($472M).
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- No meaningful interest burdenLittle or no interest expense reported
What this means
Little or no interest expense reported, the business isn't leaning on lenders to operate.
- Net cash, debt-freeCash $208M − debt $0
What this means
Cash and short-term investments exceed every dollar of debt by $208M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Negative, funded by othersDSO 41 + DIO 48 − DPO 175 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. A negative cycle is a quiet moat: suppliers and customers fund the operation (Buffett's “float”), the company grows on other people's money.
Is it a good business?
- Not enough dataIndustry peers: median -2%
What this means
The filing data didn't include the inputs for this check.
- Solid through the cycle3-yr median margin, range -23%–29%; latest $171M = operating cash $171M − maintenance capex $708KIndustry peers: median 4%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 29% of revenue this year, a 12% median across 3 years. Treating stock comp as the real expense it is (less $643M of SBC) leaves ($472M).
- Loss, but cash-generativeNet income ($528M) · cash from operations $171M
What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.
How is the cash used?
- Reinvests most of itDividends + buybacks $65M ÷ Owner Earnings $171M
What this means
Of $171M Owner Earnings, $65M (38%) went back to shareholders, $0 dividends, $65M buybacks. But the buybacks barely exceed stock issued to employees ($643M SBC), net of dilution, little was truly returned. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 0.14×HarvestingCapex $708K ÷ depreciation $5M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 0 of 2 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size MissRevenue ≥ $2B · $588M
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity MissCurrent ratio ≥ 2× · 1.47×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-2.75/share (latest year $-6.72), the averaged base the calculator's gate runs on, and book value is $2.27/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Does AI threaten the moat?
Elevated contestabilityThe product is software or information, the very thing capable AI now produces more cheaply, so the moat is more contestable than the record alone implies.
Its FY2025 10-K names artificial intelligence as a competitive threat.
“Our competitors, as well as a number of other companies, within and outside the healthcare industry, are pursuing new delivery devices, delivery technologies, sensing technologies, procedures, drugs, and other therapies, including solutions driven by AI and machine learning, for the monitoring and treatment of MSK cond…”
AI has collapsed the cost of building a capable substitute for the very thing this business sells. When a credible alternative can be assembled for a fraction of the incumbent's price, it is pricing power that erodes first, not revenue tomorrow. The live question is whether the moat survives that, not whether it held in the past. Whether that question is answerable at all is yours to decide, against your own circle of competence.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Mar 31, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$405M
- Receivables$115M
- Inventory$14M
- Other current assets$6M
- Accounts payable$69M
- Other current liabilities$345M
From the company's latest filing.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid.
- Insider ownership1.5%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
- Stock-based compensation$643M
The slice of the business handed to employees in shares this year, 109% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
What an owner would ask, FY2025
read the 10-K →- Which reported numbers are a judgment call?Management names Revenue recognition, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, IT Services & Consulting
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| GDRXGoodRx Holdings Inc. | $797M | — | 5.1% | 2% | 20% |
| UPWKUpwork Inc. | $788M | 73% | -5.3% | -7% | 3% |
| LZLegalZoom.com Inc. | $756M | 66% | 3.3% | — | 15% |
| CARSCars.com Inc. Common Stock | $723M | 90% | 8.1% | 5% | 21% |
| HNGEHinge Health Inc. | $588M | 77% | -44.6% | — | 12% |
| IBEXIBEX Limited | $558M | — | 7.7% | 31% | 4% |
| LIFLife360 Inc. | $489M | 76% | -15.2% | -28% | -4% |
| YEXTYext Inc. | $447M | 75% | -24.8% | -85% | 1% |
| Group median | — | 76% | -1.0% | — | 8% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Hinge Health Inc. has delivered.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $209M on 79M shares outstanding (a weighted basic average, the only count this filer tags); net cash $405M. The if-converted diluted count is 82M, 5% above the shares outstanding: the dilution overhang (convertibles, options) a buyer inherits. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← HMN its page in the Manual HNI →
Industry order: ← GRVY the IT Services & Consulting chapter IBEX →